<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zakrzewski P</submitter><funding>Medical Research Foundation</funding><funding>GW4-CAT Wellcome Trust Clinical PhD fellowship</funding><funding>NHS Blood and Transplant R&amp;D grant</funding><funding>NIHR BTRU in partnership with NHSBT</funding><funding>Barth Syndrome Foundation</funding><funding>Bristol and Weston Hospitals Charity</funding><funding>CRUK Scotland Institute core funding</funding><funding>Wellcome Trust Dynamic Cell PhD studentship</funding><funding>Wellcome Trust</funding><funding>NHS Blood and Transplant R&amp;amp;D grant</funding><funding>Medical Research Foundation (MRF)</funding><pagination>1590-1619</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11933368</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(6)</volume><pubmed_abstract>Barth syndrome (BTHS) is a rare genetic disease caused by mutations in the TAFAZZIN gene. It is characterized by neutropenia, cardiomyopathy and skeletal myopathy. Neutropenia in BTHS is associated with life-threatening infections, yet there is little understanding of the molecular and physiological causes of this phenomenon. We combined bone marrow analysis, CRISPR/Cas9 genome editing in hematopoietic stem cells and functional characterization of circulating BTHS patient neutrophils to investigate the role of TAFAZZIN in neutrophils and their progenitors. We demonstrate a partial cell intrinsic differentiation defect, along with a dysregulated neutrophil inflammatory response in BTHS, including elevated degranulation and formation of neutrophil extracellular traps (NETs) in response to ca</pubmed_abstract><journal>EMBO reports</journal><pubmed_title>Tafazzin regulates neutrophil maturation and inflammatory response.</pubmed_title><pmcid>PMC11933368</pmcid><funding_grant_id>IS-BTU-1214-10032</funding_grant_id><funding_grant_id>MR/R02149X/1</funding_grant_id><funding_grant_id>A31287</funding_grant_id><funding_grant_id>WP15-05</funding_grant_id><pubmed_authors>Zakrzewski P</pubmed_authors><pubmed_authors>Amulic B</pubmed_authors><pubmed_authors>Groves SJ</pubmed_authors><pubmed_authors>Toye AM</pubmed_authors><pubmed_authors>Steward C</pubmed_authors><pubmed_authors>Cela D</pubmed_authors><pubmed_authors>Strathdee D</pubmed_authors><pubmed_authors>Nobbs AH</pubmed_authors><pubmed_authors>Gibbs W</pubmed_authors><pubmed_authors>Fleming K</pubmed_authors><pubmed_authors>Pike T</pubmed_authors><pubmed_authors>Anderson E</pubmed_authors><pubmed_authors>Roberts K</pubmed_authors><pubmed_authors>Rice CM</pubmed_authors><pubmed_authors>Ponce-Garcia FM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tafazzin regulates neutrophil maturation and inflammatory response.</name><description>Barth syndrome (BTHS) is a rare genetic disease caused by mutations in the TAFAZZIN gene. It is characterized by neutropenia, cardiomyopathy and skeletal myopathy. Neutropenia in BTHS is associated with life-threatening infections, yet there is little understanding of the molecular and physiological causes of this phenomenon. We combined bone marrow analysis, CRISPR/Cas9 genome editing in hematopoietic stem cells and functional characterization of circulating BTHS patient neutrophils to investigate the role of TAFAZZIN in neutrophils and their progenitors. We demonstrate a partial cell intrinsic differentiation defect, along with a dysregulated neutrophil inflammatory response in BTHS, including elevated degranulation and formation of neutrophil extracellular traps (NETs) in response to ca</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-02T21:12:32.111Z</modification><creation>2026-05-29T03:06:29.046Z</creation></dates><accession>S-EPMC11933368</accession><cross_references><pubmed>39962231</pubmed><doi>10.1038/s44319-025-00393-w</doi></cross_references></HashMap>